期刊文献+

莨菪烷类M3受体拮抗剂的合成、活性测定及其分子结构与活性的定量关系 被引量:1

Synthesis, activity determination of tropane compounds as muscarinic M3 receptor antagonists and quantitative relationship between their molecular structure and activity
下载PDF
导出
摘要 目的·建立莨菪烷类M3受体拮抗剂的定量结构-活性关系(quantitative structure-activity relationship,QSAR)模型,为后续高活性分子的设计提供指导。方法·以3α-羟基莨菪烷(J0)为起始物,通过对莨菪烷母核C-3α位的结构进行改良,合成新莨菪烷类化合物(J1~J6)。选取富含M3受体的豚鼠气道环为测试样本,通过离体组织功能实验,测试新莨菪烷类化合物对M3受体的拮抗参数(antagonistic parameter,pA_2)。利用新合成的和课题组原有的莨菪烷类化合物的pA_2建立QSAR模型,通过分析该模型的能量场(立体场、静电场)对莨菪烷类化合物拮抗活性的影响,获得结构优化提示。结果·本研究共合成6个新莨菪烷类化合物。上述化合物均可对M3受体产生拮抗作用,其中J4的拮抗活性最大(pA_2=7.992)。QSAR模型的交叉验证相关系数平方(q^2)为0.585,非交叉验证相关系数平方(r^2)为0.993。结论·在化合物C-3α位的R取代基中,环上π键的共轭程度较大且有O或N原子参与共轭时,可明显提高化合物的拮抗活性。 Objective · To provide theoretical guidance for the design of molecules with high activity by building the quantitative structure-activity relationship (QSAR) model for tropane compounds as muscarinic M3 receptor antagonists. Methods · Six compounds (J1-J6) were prepared with 3α-hydroxy-tropane (J0) as the starting material by modifying the structure in C-3α position of the tropane skeleton. The antagonistic activity of new tropane compounds to muscarinic M3 receptors on tracheal rings of guinea pigs was evaluated by functional assays in vitro. The antagonistic parameters (pA 2 ) of new tropane compounds prepared in this paper and former studies were applied to construct the QSAR model. The information about structural optimization was acquired by analyzing the effect of steric field and electrostatic field of model on activity of tropane compounds. Results · The six new tropane compounds showed obvious antagonistic activity against M3 receptors. Among them, J4 had the greatest activity (pA 2 =7.992). The cross-validation correlation coefficient squared (q 2 ) and the non-cross-validated correlation coefficient squared (r 2 ) of the QSAR model were 0.585 and 0.993, respectively. Conclusion · The antagonistic activity to muscarinic M3 receptors can be obviously improved, when the conjugating extent of π-bonds is large and O or N atoms participate in conjugation on the rings in the R-substituting group at C-3α position of the compounds.
作者 金玉杰 刘慧中 胡优敏 张建华 蔡玉兴 李宁 钮因尧 JIN Yu-jie;LIU Hui-zhong;HU You-min;ZHANG Jian-hua;CAI Yu-xing;LI Ning;NIU Yin-yao(Chemicobiological Laboratory, Experimental Teaching Center of Basic Medicine, Shanghai Jiao Tong University College of Basic Medical Sciences, Shanghai 200025,China;Functional Training Laboratory, Experimental Teaching Center of Basic Medicine, Shanghai Jiao Tong University College of Basic Medical Sciences, Shanghai 200025, China;Department of Chemistry, Shanghai Jiao Tong University College of Basic Medical Sciences, Shanghai 200025, China)
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2019年第4期366-371,共6页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市卫生和计划生育委员会科研课题(201440575) 上海交通大学医学院科技基金(14XJ10006)~~
关键词 慢性阻塞性肺疾病 莨菪烷 M3 受体拮抗剂 定量结构-活性关系 chronic obstructive pulmonary disease (COPD) tropane M3 receptor antagonist quantitative structure-activity relationship (QSAR)
  • 相关文献

参考文献4

二级参考文献32

  • 1欧美贤,史一鸣,刘慧中,崔永耀,朱亮,钮因尧,陈红专,陆阳.莨菪烷类化合物的合成及其对M_3受体的拮抗活性[J].上海交通大学学报(医学版),2011,31(7):909-912. 被引量:6
  • 2杨丽敏,钮因尧,谢一凡,冯菊妹,陈红专,陆阳.3α-磺酰氧(氨)取代的莨菪烷衍生物的合成及其生物活性[J].上海第二医科大学学报,2005,25(3):220-222. 被引量:4
  • 3钮因尧,杨丽敏,崔永耀,朱亮,冯菊妹,陈红专,陆阳.3-取代-6β-乙酰氧基莨菪烷的合成及其生物活性研究[J].化学世界,2005,46(5):299-301. 被引量:3
  • 4Fitzgerald MF,Fox JC.Emerging trends in the therapy of COPD:bronchodilators as mono-and combination therapies[J].Drug Discov Today,2007,12(11-12):472-478.
  • 5Gross NJ.Anticholinergic agents in asthma and COPD[J].Eur J Pharmacol,2006,533(1-3):36-39.
  • 6Meacher R,Cordingley J.Respiratory system:applied pharmacology[J].Anaesth Inten Care Med,2005,6(12):419-421.
  • 7Restrepo RD.Use of inhaled anticholinergic agents in obstructive airway disease[J].Respir Care,2007,52 (7):833-851.
  • 8Cazzola M.Aclidinium bromide,a novel long-acting muscarinic M3 antagonist for the treatment of COPD[J].Curr Opin Investig Drugs,2009,10(5):482-490.
  • 9Profits M,Bonanno A,Siena L,et al.Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERKdependent mechanism[J].Eur J Pharmacol,2008,582 (1-3):145-153.
  • 10Wan ZH,Laine DI,Yan HX,et al.Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1] octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD[J].Bioorg Med Chem Lett,2009,19(16):4560-4562.

共引文献12

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部